Fig. 4From: Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)Mean (SD) endometrial thickness over the course of r-hFSH treatment (ITT population)Back to article page